Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias

Blood

Volumn 89, Issue 6, 1997, Pages 2036-2041

  Fischer, Konstanze ^b   Fröhling, Stefan ^b   Scherer, Stephen W ^b   Brown, Jill McAllister ^b   Scholl, Claudia ^b   Stilgenbauer, Stephan ^b   Tsui, Lap Chee ^b   Lichter, Peter ^b   Döhner, Hartmut ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHROMOSOME 7Q; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION; CHROMOSOME MAP; CHROMOSOME TRANSLOCATION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; MYELODYSPLASTIC SYNDROME; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 1842295700     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.6.2036     Document Type: Article

References (27)

1. Fourth International Workshop on Chromosomes in Leukemia 1982: Abnormalities of chromosome 7 resulting in monosomy 7 or in deletion of the long arm (7q-): Review of translocations, breakpoints and associated abnormalities. Cancer Genet Cytogenet 11:251, 1984
2. Mitelman F, Brandt L, Nilsson PG: Relation among occupational exposure to potential mutagenic/carcinogenic agents, clinical findings, and bone marrow chromosomes in acute nonlymphocytic leukemia. Blood 52:1229, 1978
3. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD: Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: Further evidence for characteristic abnormalities of chromosomes nos. 5 and 7. J Clin Oncol 3:325, 1986
4. Luna-Fineman S, Shannon KM, Lange BJ: Childhood monosomy 7: Epidemiology, biology, and mechanistic implications. Blood 85:1985, 1995
5. Bloomfield CD, de la Chapelle A: Chromosome abnormalities in acute nonlymphocytic leukemia: Clinical and biological significance. Semin Oncol 14:372, 1987
6. Neuman WL, Rubin CM, Rios RB, Larson RA, Le Beau MM, Rowley JD, Vardiman JW, Schwartz JL, Farber R: Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders. Blood 79:1501, 1992
7. Johansson B, Mertens F, Mitelman F: Cytogenetic deletion maps of hematologic neoplasms: Circumstantial evidence for tumor suppressor loci. Genes Chromosom Cancer 8:205, 1993
8. Rodrigues Pereira Velloso E, Michaux L, Ferrant A, Hernandez JM, Meeus P, Dierlamm J, Criel A, Louwagie A, Verhoef G, Boogaerts M, Michaux JL, Bosly A, Mecucci C, Van den Berghe H: Deletions of the long arm of chromosome 7 in myeloid disorders: Loss of band 7q32 implies worst prognosis. Br J Haematol 92:574, 1996
9. Le Beau MM, Espinosa R III, Davis EM, Eisenbart JD, Larson RA, Green ED: Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood 88:1930, 1996
10. Kere J, Ruutu T, Davies KA, Roninson IB, Watkins PC, Winqvist R, de la Chapelle A: Chromosome 7 long arm deletion in myeloid disorders: A narrow breakpoint region in 7q22 defined by molecular mapping. Blood 73:230, 1989
11. Kere J, Donis-Keller H, Ruutu T, de la Chapelle A: Chromosome 7 long-arm deletions in myeloid disorders: Terminal DNA sequences are commonly conserved and breakpoints vary. Cytogenet Cell Genet 50:226, 1989
12. Lewis S, Abrahamson G, Boultwood J, Fidler C, Potter A, Wainscoat JS: Molecular characterization of the 7q deletion in myeloid disorders. Br J Haematol 93:75, 1996
13. Johnson EJ, Scherer SW, Osborne L, Tsui LC, Oscier D, Mould S, Cotter FE: Molecular definition of a narrow interval at 7q22:1 associated with myelodysplasia. Blood 87:3579, 1996
14. Scherer SW, Tompkins BJF, Tsui LC: A human chromosome 7-specific genomic DNA library in yeast artificial chromosomes. Mammal Genome 3:179, 1992
15. Kunz J, Scherer SW, Klawitz I, Soder S, Du YZ, Speich N, Kalff-Suske M, Heng HHQ, Tsui LC, Grzeschik KH: Regional localization of 725 human chromosome 7-specific yeast artificial chromosome clones. Genomics 22:439, 1994
16. Scherer SW, Poorkaj P, Trask B, Soder S, Allen T, Nunez M, Geshuri D, Wong E, Belloni E, Little S, Zhou L, Becker D, Kere J, Ignatius J, Niikawa N, Fukushima Y, Hasegawa T, Weissenbach J, Boncinelli E, Massa H, Tsui LC, Evans JP: Physical mapping of the split hand/split foot locus (SHFD1) on chromosome 7 and implication in syndromic ectrodactyly. Hum Mol Genet 3:1345, 1994
17. Tsui LC, Donis-Keller H, Grzeschik KH: Report of the Second International Workshop on Human Chromosome 7 Mapping 1994. Cytogenet Cell Genet 71:1, 1995
18. Mitelman F (ed): ISCN (1995): An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, S. Karger, 1995
19. Takahara K, Osborne L, Elliot RW, Tsui LC, Scherer SW, Greenspan DS: Fine mapping of the human and mouse genes for the type I procollagen COOH-terminal proteinase enhancer protein. Genomics 31:253, 1996
20. Mackay M, Fantes J, Scherer SW, Boyle S, West K, Tsui LC, Belloni E, Lutz E, Van Heyningen V, Harmar AJ: Chromosomal localization in mouse and human of the vasoactive intestinal peptide receptor type 2 gene: A possible contributor to the holoprosencephaly 3 phenotype. Genomics 37:345, 1996
21. Lengauer C, Green ED, Cremer T: Fluorescence in situ hybridization of YAC clones after ALU-PCR amplification. Genomics 13:286, 1992
22. Lichter P, Tang CC, Call K, Hermanson G, Evans GA, Housman D, Ward DC: High resolution mapping of human chromosome 11 by in situ hybridization with cosmid clones. Science 247:64, 1990
23. Fischer K, Scholl C, Salat J, Fröhling S, Stilgenbauer S, Bentz M, Lichter P, Döhner H: Design and validation of DNA probe-sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia. Blood 88:3962, 1996
24. Döhner H, Fischer K, Bentz M, Hansen K, Benner A, Cabot G, Diehl D, Schlenk R, Coy J, Stilgenbauer S, Volkmann M, Galle PR, Poustka A, Hunstein W, Lichter P: p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood 85:1580, 1995
25. Stilgenbauer S, Liebisch P, James MR, Schröder M, Schlegelberger B, Fischer K, Bentz M, Lichter P, Döhner H: Molecular cytogenetic delineation of a novel critical genomic region in chromosome bands 11q22.2-q23.1 in lymphoproliferative disorders. Proc Natl Acad Sci USA 93:11837, 1996
26. Brown AG, Ross FM, Dunne EM, Steel CM, Weir-Thompson EM: Evidence for a new tumour suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nat Genet 3:67, 1993
27. Heng HHQ, Shi XM, Scherer SW, Andrulis IL, Tsui LC: Refined localization of the asparaginase synthetase gene (ASNS) to chromosome 7, region q21.3, and characterization of the somatic cell hybrid line 4AF/106/KO15. Cytogenet Cell Genet 66:135, 1994